1,2 diarylbenzimidazoles and their pharmaceutical use

Karl Dr. Rudolphi, Ulrich Dr. Gebert, Hans-Peter Prof. Dr. Schubert, Barbara Dr. Kittner, John J. Dr. Grome, Use of xanthine derivatives for the manufacture of a medicament for the treatment of secondary nerve cell damages and function disorders after head-brain-traumata ,(1992)

Günter Dr. Dipl.-Chem. Linz, Frank Dr. Dipl.-Chem. Himmelsbach, Johannes Dr. Dipl.-Chem. Weisenberger, Thomas Dr. Dipl.-Chem. Müller, Helmut Dr. Dipl.-Chem. Pieper, Elke Dr. Dipl.-Bio. Seewaldt-Becker, Volkhard Dr. Dipl.-Chem. Austel, Condensed 5-membered ring heterocycles, process for their preparation and medicaments containing them ,(1992)

Mark A. Muhlhauser, Smriti Iyengar, Karl B. Thor, Methods of treating or preventing interstitial cystitis Official Gazette of the United States Patent and Trademark Office Patents. ,(1997)

Palle Christophersen, Dan Peters, Elsebet Oestergaard Nielsen, Oskar Axelsson, Imidazole compounds, their preparation and use ,(1993)

Janak Khimchand Padia, Bharat Kalidas Trivedi, Bradley Dean Tait, Joseph Anthony Cornicelli, Method for treating and preventing inflammation and atherosclerosis ,(1996)

James A. Monn, William H. W. Lunn, Dennis M. Zimmerman, Methods for treating a physiological disorder associated with β-amyloid peptide ,(1994)

Patrick L McGeer, Edith G McGeer, The possible role of complement activation in Alzheimer disease Trends in Molecular Medicine. ,vol. 8, pp. 519- 523 ,(2002) , 10.1016/S1471-4914(02)02422-X

Yoichi Nakamura, Regulating factors for microglial activation. Biological & Pharmaceutical Bulletin. ,vol. 25, pp. 945- 953 ,(2002) , 10.1248/BPB.25.945

M. Thomas, W. Le, Minocycline: Neuroprotective mechanisms in Parkinson's disease Current Pharmaceutical Design. ,vol. 10, pp. 679- 686 ,(2004) , 10.2174/1381612043453162

Norman A. Nelson, Pyridinyl substituted benzimidazoles and quinoxalines ,(1982)